Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 2 | Virology Journal

Fig. 2

From: The immunogenicity of PRV ΔgE/TK/UL49.5 three-gene-deleted vaccine in mice

Fig. 2

Purification and identification of PRV strains. (A) Plaque purification of PRV ΔgE/TK/UL49.5/EGFP+ strain for fluorescence visual field. (B) Plaque purification of PRV ΔgE/TK/UL49.5/EGFP+ strain for bright visual field, red circles represent the plaque of PRV ΔgE/TK/UL49.5/EGFP+. (C) Plaque purification of PRV ΔgE/TK/UL49.5 strain for fluorescence visual field. (D) Plaque purification of PRV ΔgE/TK/UL49.5 strain for bright visual field, red circles represent the plaque of PRV ΔgE/TK/UL49.5. (E) PCR analysis of different PRV strains with primers UL49.5-F/R. Lane 1, PRV ΔgE/TK/UL49.5; lane 2, PRV ΔgE/TK/UL49.5/EGFP+; lane 3, PRV QYY2012; lane 4, negative control; M, DL2000 DNA Marker

Back to article page